Peptide Comparison
Thymopentin (TP-5)vsThymosin Alpha-1
Immune-boosting pentapeptide fragment that enhances T-cell function and dendritic cell maturation
Your immune system's master trainer—a naturally occurring thymus peptide that wakes up tired immune cells, helps your body fight infections, and keeps your defenses sharp as you age.
At a Glance
Quick
comparison
Dose Range
Thymopentin (TP-5)
1–2 mg
Thymosin Alpha-1
1.6–3.2 mg
Frequency
Thymopentin (TP-5)
Once daily
Thymosin Alpha-1
Twice weekly
Administration
Thymopentin (TP-5)
Subcutaneous injection
Thymosin Alpha-1
Subcutaneous injection
Cycle Length
Thymopentin (TP-5)
4-6 weeks
Thymosin Alpha-1
8-12 weeks
Onset Speed
Thymopentin (TP-5)
Moderate (1-2 weeks)
Thymosin Alpha-1
Moderate (1-2 weeks)
Evidence Level
Thymopentin (TP-5)
Moderate human trials (Phase 1-2)
Thymosin Alpha-1
Moderate human trials (Phase 1-2)
Efficacy
Benefit
ratings
Immune Enhancement
Cardiovascular Support
Post-Recovery Support
Immune Activation
Infection Fighting
Immune Balance
Technical Data
Compound
specifications
Thymopentin (TP-5)
Molecular Formula
C30H49N9O9
Molecular Weight
679.8
Half-Life
30 seconds to few minutes in plasma
Bioavailability
Sustained release via subcutaneous route
CAS Number
69558-55-0
Thymosin Alpha-1
Molecular Formula
C129H215N33O55
Molecular Weight
3108.32 g/mol
Half-Life
Approximately 2 hours
Bioavailability
High when injected subcutaneously (rapid absorption, peak at ~2 hours)
CAS Number
62304-98-7
Protocols
Dosing
tiers
Thymopentin (TP-5)
Thymosin Alpha-1
Applications
Best
suited for
Thymopentin (TP-5)
Immune System Enhancement
Thymopentin directly increases T-cell function and promotes dendritic cell maturation, making it ideal for people seeking to boost immune response naturally
Cardiac Health Support
Clinical trials show thymopentin improves ejection fraction and exercise capacity in elderly heart failure patients while enhancing immune markers
Post-Surgery Recovery
Helps restore immune function after major surgery and protects important immune responses during recovery period
Thymosin Alpha-1
Chronic Hepatitis B or C Support
Thymosin Alpha-1 has its strongest clinical evidence here. Multiple trials show it helps clear viral loads and normalize liver enzymes, especially when combined with antiviral medications. It's approved in over 30 countries specifically for hepatitis treatment.
Cancer Treatment Support
When used alongside chemotherapy, Thymosin Alpha-1 may help maintain immune function that chemo tends to suppress. Research in lung cancer, melanoma, and liver cancer shows improved outcomes when added to standard treatments. It helps your immune system keep fighting even during tough treatments.
Age-Related Immune Decline
As you age, your thymus shrinks and produces less thymosin naturally—a process called immunosenescence. Supplementing with Thymosin Alpha-1 may help compensate, keeping your immune defenses more youthful and responsive. Think of it as replacing what your body makes less of over time.
Severe Infection Recovery
In sepsis and critical infections, Thymosin Alpha-1 has shown promise for reducing mortality by helping restore immune balance. It's particularly interesting because it modulates immunity rather than just boosting it—calming overreaction while enhancing pathogen-fighting ability.
Safety Profile
Side
effects
Thymopentin (TP-5)
Common
- Local injection site reaction
- Mild fatigue
- Transient fever
Uncommon
- Muscle aches
- Mild headache
Serious
- Allergic reaction
Thymosin Alpha-1
Common
- Injection site reactions
- Mild fatigue
- Flu-like symptoms
Uncommon
- Mild fever
- Lymph node awareness
Serious
- Allergic reaction
Research Status
Safety
& evidence
Thymopentin (TP-5)
Evidence Level
Moderate human trials (Phase 1-2)
FDA Status
Research compound
Safety Overview
Thymopentin is well-tolerated with minimal side effects reported in clinical trials. Most adverse events are mild and local. No serious safety concerns have emerged from decades of clinical use in China and Europe.
Contraindications
- xPregnancy and breastfeeding
- xActive malignancy (without medical supervision)
- xSevere immunosuppression
- xHypersensitivity to peptide medications
Thymosin Alpha-1
Evidence Level
Moderate human trials (Phase 1-2)
FDA Status
FDA approved for other use
Safety Overview
Thymosin Alpha-1 has one of the most extensive safety records of any peptide, with decades of clinical use across multiple countries. Studies consistently report minimal side effects—mostly limited to mild injection site reactions. The 2-hour half-life means it doesn't accumulate in your system. It's been used safely in thousands of patients with hepatitis, cancer, and other serious conditions.
Contraindications
- xOrgan transplant recipients on immunosuppressants
- xActive autoimmune disease flares
- xKnown allergy to thymosin peptides
- xPregnancy or breastfeeding
- xChildren under 18 without medical supervision
Decision Guide
Which is
right for you?
Choose Thymopentin (TP-5) if...
- Immune system strengthening
- Recovering from illness or surgery
- Managing autoimmune conditions
- Supporting cardiac health in elderly patients
Choose Thymosin Alpha-1 if...
- Immune system strengthening
- Chronic infection support
- Cancer adjunct therapy
- Healthy aging immune support